Cite
APA Citation
Yoo, D., Park, W., Brzosko, M., Géher, P., Andersone, D., Jaworski, J., Rekalov, D., Oparanov, B., Kausiene, R., Pacheco-Tena, C., & Lee, S. (2014). tHU0159 Disease Activity Assessment Using the DAS28, CDAI and SDAI and Effect of Anti-Drug Antibody on Clinical Response in a Randomized, Double-Blind, Comparative Trial of CT-P13 and Innovator Infliximab: Planetra Study. Annals of the rheumatic diseases, 73, 235. http://access.bl.uk/ark:/81055/vdc_100135163150.0x00005b